# Age-Associated Splicing Events in the Integrative Longevity Omics (ILO) Cohort

## TL;DR

This study explores how alternative splicing changes with age in centenarians and older adults, identifying splicing events linked to exceptional longevity.

## Contribution

The study identifies age-associated splicing events in centenarians and suggests a reversal of typical aging splicing patterns.

## Key findings

- 731 significant age-associated splicing events were identified, mostly skipped exons and mutually exclusive exons.
- A skipped exon in NFYC showed reversed splicing trends in centenarians compared to controls.
- Centenarians deviate from normal aging splicing patterns according to residual analysis.

## Abstract

Alternative splicing regulates transcript diversity and is increasingly recognized as a key mechanism in aging and age-related disease, yet little is known about how splicing contributes to human exceptional longevity. We analyzed RNA-seq data from the Integrative Longevity Omics (ILO) cohort, which includes centenarians (the oldest-old, age ≥100) and older adult controls (ages 60–89), to identify age-associated splicing events. Splicing was quantified with rMATS to estimate percent-spliced-in (PSI) values across five event categories, and quasi-binomial regression was used to model splicing changes with age. This analysis identified 731 significant age-associated events (false discovery rate < 0.05), the majority of which were mutually exclusive exons and skipped exons. A strong example is a skipped exon in Nuclear Transcription Factor Y subunit C (NFYC), a regulator of senescence-associated pathways. In controls, NFYC PSI trended downward with age, whereas in centenarians, PSI increased significantly with age, suggesting a reversal of midlife splicing trajectories. Residual analysis comparing observed PSI to predictions from a spline model of normal aging further suggests that centenarians deviate from normal aging patterns. This work describes age-associated splicing events in a population enriched for centenarians and provides preliminary evidence for a candidate splicing signature of exceptional longevity. Ongoing analyses will evaluate functional pathways and clinical relevance in independent cohorts.